Unknown PHASE2 INTERVENTIONAL 2-arm NCT04551755

Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19

The Safety and Efficacy Outcome of Ivermectin Plus Doxycycline in Treatment of RT-PCR Positive Adult Mild Covid-19 Cases: a Randomized Double Blind Placebo Controlled Trial

Sponsor: Bangladesh Medical Research Council (BMRC)

Conditions Covid19

Interventions Ivermectin and Doxycycline Placebo

Updated 5 times since 2020 Last updated: Sep 15, 2020 Started: Sep 30, 2020 Primary completion: Nov 30, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04551755, this PHASE2 trial focuses on Covid19 and remains ongoing. Sponsored by Bangladesh Medical Research Council (BMRC), it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Oct 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2022 [monthly]

Not Yet Recruiting PHASE2
Oct 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bangladesh Medical Research Council (BMRC)

Data source: Bangladesh Medical Research Council (BMRC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.